NCT07462377
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07462377
Title A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors EpiBiologics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
START Los Angeles RECRUITING Los Angeles California 90025 United States Details
Astera Cancer Care RECRUITING East Brunswick New Jersey 08816 United States Details
START New York Long Island NOT_YET_RECRUITING Lake Success New York 11042 United States Details
Sarah Cannon and HCA Research Institute RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center NOT_YET_RECRUITING Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutics (START) RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field